Neurological complications of neurofibromatosis type 1 in adulthood. - Wikidata - awgldk - TriplyDB

Neurological complications of neurofibromatosis type 1 in adulthood.

Neurological complications of neurofibromatosis type 1 in adulthood.

http://www.wikidata.org/entity/Q48254120

about

Von recklinghausens disease: a series of four cases with variable expression Occipital peripheral nerve stimulation in the management of chronic intractable occipital neuralgia in a patient with neurofibromatosis type 1: a case report.Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006)A patient with neurofibromatosis type 1 and Charcot-Marie-Tooth disease type 1B.Recognition and management of childhood cancer syndromes: a systems approach.Augmented sodium currents contribute to the enhanced excitability of small diameter capsaicin-sensitive sensory neurons isolated from Nf1+/⁻ mice.N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice.Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.Epilepsy in neurofibromatosis 1.Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression.Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis: Abscess Formation in the Tumor Leading to Bacteremia and Seizure.Carpal tunnel syndrome due to a plexiform neurofibroma of the median nerve in a neurofibromatosis type 1 patient: clinical approach.Glomus tumor of the thenar eminence in neurofibromatosis type 1: case report and literature review.Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma Neurocutaneous syndrome: a prospective study.Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1.Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1.Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1.Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 Monogenic vessel diseases related to ischemic stroke: a clinical approach.Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1.Pediatric neurofibromatosis 1 and parental stress: a multicenter study Non-optic glioma in adults and children with neurofibromatosis 1.Giant plexiform neurofibroma with hemorrhage in cranio-maxillofacial region as depicted on CT and MRI.NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.CRMP2 is necessary for Neurofibromatosis type 1 related pain.Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1.Large Cervical Vagus Nerve Tumor in a Patient with Neurofibromatosis Type 1 Treated with Gross Total Resection: Case Report and Review of the Literature.Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.Treatment of neurofibromatosis type 1.The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.Young stroke due to vascular anomaly from neurofibromatosis type 1.Hydrocephalus following bilateral dumbbell-shaped c2 spinal neurofibromas resection and postoperative cervical pseudomeningocele in a patient with neurofibromatosis type 1: a case report.Autopsy case of concurrent Huntington's disease and neurofibromatosis type 1.A case report of cervical neurofibrosarcoma: Clinical presentation, treatment and outcome.Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.Optic Pathway Gliomas in Neurofibromatosis Type 1.

P2860

Q30389804-7F87D49E-BEEA-476D-9083-2999E8A05627 Q30475392-840F056D-AB37-4885-A882-D3CC6871285D Q30475780-FD5D56E6-11D8-482C-B022-F40457613A15 Q33762006-ACFA6A63-17AD-42BC-B8E3-B7A3E8DE2D3F Q33772586-A0EB80FC-75A4-4E20-A407-0D7AA8EDD2C4 Q33783815-507B196C-2437-4E98-8CA6-1178A2D0F12A Q33822127-3E183396-532E-4533-96D1-32D55E97EA2B Q34128892-EBB45ADA-191B-4BF3-9C89-4E1BC4927403 Q34208209-5C856070-DB8F-41DD-8CA1-6972F3062F0A Q34319451-C74A5585-9EB6-40C3-994F-D640A369DBBC Q34336087-76E5C6C6-D085-48CC-B7C9-7D258D32CE1F Q34819064-10CA738E-8DFB-45DC-9FC5-575A9A54599F Q35023829-3EB85CA0-AB63-45F4-8A5B-6377602BBC2D Q35088274-2E3010A3-A070-4385-9BA0-A7534F43B46D Q35228994-A343478A-02CC-49F0-8378-E04A743033CB Q36142283-A101D0E8-8C5A-4B80-A70A-ADBDDB4B5D44 Q36172605-4E97A14D-6AF1-4C5C-8531-AE24B35FD27A Q36296527-3D0E626C-DDE4-41B9-84AA-FA91E470A774 Q36653938-50218182-CFE6-4FD4-81F1-DD872B2E197E Q36853643-282F46EC-3B8E-4285-9D96-B6388AEAF223 Q36901613-CCB2C290-A4D4-4C54-B095-ACEE81E354D9 Q37524978-F25E6CD2-3DEE-48FA-B12F-5322DEA6D259 Q37645352-7EFFAE69-C72B-4B93-B100-9BE56CAA1D59 Q37746411-328B4862-DEEE-429E-B552-5A1C4AE25F42 Q38435406-EACD843B-B8EB-47CB-935A-E558EB31C2A8 Q38610238-4ABB89E9-1A99-4300-9C06-C935640D11A5 Q38831060-D052AE36-700E-4043-88DF-0FCB5C1A644F Q38831774-11469836-4517-4883-9084-E701AEE776B3 Q39080526-E50CE376-BB1A-4796-BE1A-E0377F0BA5D5 Q39555847-256BA96E-5131-4DDE-AFC8-01F28A4442E9 Q41008080-8549198A-F93E-4964-ABE8-B66116045424 Q41039624-E04B0F40-ECCB-4759-B12F-6F3C69E742F4 Q41468709-40E72C41-D66C-4824-9DE7-1BB199017D7B Q41867900-6DF2E6E5-465E-466A-AC74-5C67B14434B5 Q42966402-0306CA17-C5F1-467E-8438-84A51600115D Q45297647-2EF8A10E-952A-4DC9-8806-26E705982CC8 Q46210018-1714A276-2360-4857-8ED0-A8C877B7980C Q46478924-8698385B-02BB-489E-81E0-C97805758E9C Q46644311-DBF5B391-709C-491D-8DBC-F75DECD7253E Q47779215-15CD10FE-17AF-437B-A853-D2DDF3EA149A

P2860

Neurological complications of neurofibromatosis type 1 in adulthood.

http://www.wikidata.org/entity/Q48254120

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Neurological complications of neurofibromatosis type 1 in adulthood.

@en

Neurological complications of neurofibromatosis type 1 in adulthood.

@nl

type

label

Neurological complications of neurofibromatosis type 1 in adulthood.

@en

Neurological complications of neurofibromatosis type 1 in adulthood.

@nl

prefLabel

Neurological complications of neurofibromatosis type 1 in adulthood.

@en

Neurological complications of neurofibromatosis type 1 in adulthood.

@nl

P1433

Q48254120-7DCDBE6C-1FBB-4E80-8CE5-06C78996FFBE

P1476

Q48254120-B5BA4648-9775-4B51-A368-A2481C7BFCA1

P2093

Q48254120-034322BD-8E25-492E-AFC7-85472B0F483F

Q48254120-1B1D4E0A-6EF4-4899-8675-87BF2E4D3917

Q48254120-60CD0A1A-93E1-4E78-B71E-1033D3D89892

Q48254120-6B2D8A04-3BFA-410F-8E83-AE42E42C6607

Q48254120-8EDA4D2A-AEC1-46D1-9BC0-C75EC0A73848

Q48254120-A4CED11E-3080-42DF-AE3E-1F961E813F8C

Q48254120-D515E109-496F-4826-8F0F-B7B516E09AC4

P2860

Q48254120-09742084-13AB-486E-A95E-6AE8263DA348

Q48254120-0D791A85-0691-43A8-AB6E-CC2ABA0E402C

Q48254120-17FDEB00-A93F-4D84-AF8A-429DFA160389

Q48254120-18D606E6-5057-4235-B332-E20B6FF65906

Q48254120-195C3205-8EF9-48AB-95E5-3A0A2C25F7AD

Q48254120-25C69F94-D084-4DB2-A0E2-0B6CB137C41A

Q48254120-35648B7F-6DD2-4F2F-8875-E94519A9D0A1

Q48254120-38A54DF8-EC21-41D6-B66D-1CA361E898A7

Q48254120-4B35EFE2-8D84-42D3-B2EF-F4E383E2A401

Q48254120-64075552-1885-4AC3-9A19-55C465486A15

P304

Q48254120-EAB44164-5293-4E9A-8652-9B20D0CBAA8B

P31

Q48254120-32BABB00-CFD9-410A-AC28-62F2DFE42A2C

P356

Q48254120-7FCEF9E0-A7CD-461C-A5AC-7EC9CCF84E1D

P407

Q48254120-78D098F0-B84E-42D8-AE93-3C0E3AF104A4

P478

Q48254120-DB230B87-7C4A-448A-9DD1-3B98A1E71487

P577

Q48254120-B3837817-342F-46F9-9194-48F5429ADDA2

P698

Q48254120-06315BB3-F8E9-49EA-AC50-21846297090F

P356

P1433

P1476

Neurological complications of neurofibromatosis type 1 in adulthood.

@en

P2093

Brugières P

http://www.w3.org/2001/XMLSchema#string

Créange A

http://www.w3.org/2001/XMLSchema#string

Degos JD

http://www.w3.org/2001/XMLSchema#string

Revuz J

http://www.w3.org/2001/XMLSchema#string

Rostaing-Rigattieri S

http://www.w3.org/2001/XMLSchema#string

Wolkenstein P

http://www.w3.org/2001/XMLSchema#string

Zeller J

http://www.w3.org/2001/XMLSchema#string

P2860

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity

Schwannomatosis: a clinical and pathologic study

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations

Gliomas of the tectum and periaqueductal region of the mesencephalon.

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.

The management of brainstem gliomas in patients with neurofibromatosis 1.

Optic chiasmatic-hypothalamic glioma.

Neurofibromatosis type 1: brain stem tumours.

Prevalence of migraine.

P304

473-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/122.3.473

http://www.w3.org/2001/XMLSchema#string

P407

P478

122 ( Pt 3)

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10094256

http://www.w3.org/2001/XMLSchema#string